BRCA1 and breast cancer: Five studies used sporadic breast carcinomas, whereas the study of Tanic et al. (2012) [32] investigated miRNA expression in “familial” breast cancer, including patients with proven BRCA1 or BRCA2 germ-line mutations and non-BRCA1/2-associated familial carcinomas.